BRAND IDENTITY
BPGbio
The Brief:
To create a biology-focused identity system that appeals to a broader spectrum of acquisition investors, while conveying AI technology innovation.
This project included several infographics that helped communicate BPGbio’s Interrogative Biology® Platform which uses the power of AI to identify biomarkers for disease diagnosis.
BPGbio Inc. is a leading AI-powered, human biology focused biopharmaceutical company headquartered in the greater Boston area, Massachusetts. With its intelligent Interrogative Biology platform, BPGbio is reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery across oncology, neurology, and rare diseases.
Brand direction stylescape
Montserrat Medium
Primary Color Palette
NAi Subsidiary Logo
BPGbio’s platform NAi consists of an industry-leading and clinically annotated proprietary biobank, with purpose-built Bayesian AI. It is using the world’s fastest supercomputer, Frontier, at Oak Ridge National Laboratory (ORNL), making it the only fully-integrated high-performance computing (HPC) platform in the biopharmaceutical industry for AI-driven target nomination, discovery, and molecule design.
BPGbio’s Dx logos
BPGbio’s current clinical trial diagnostic tools for prostate cancer, pancreatic cancer, Parkinson and dermatological disease.
Website Section Icons
Interrogative Biology
Platform Infographic
shows BPGbio’s AI-generating therapeutics
and diagnostics platform stages.
Tumor Micro-Environment-Based Therapy Infographic
The Power of NAi
BPGbio’s Biology-First AI-Powered Drug Discovery Platform
BPGbio Web 2.0
Mitochondrial Biology & Protein Homeostasis
A dynamic hub of creativity blending a passion for innovation and craftsmanship for a diverse clientele.
Quick Links
© 2002 – 2024 Sense Company. All rights reserved.